For example, an HER2 classifier obtained by MALDI IMS in breast cancer samples was valid to assess the HER2 status in gastric cancer with a sensitivity and specificity comparable to other techniques such as IHC or FISH [217]. This evidence concerns the gene ERBB2 and gastric cancer.